Trial Profile
A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Follitropin alfa (Primary) ; Follitropin alfa/lutropin alfa (Primary) ; Lutropin alfa (Primary) ; Gonadotropin releasing hormone inhibitors; Gonadotropin releasing hormone stimulants
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 02 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.